These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12399766)

  • 21. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
    Boersma IH; Oranje AP; Grimalt R; Iorizzo M; Piraccini BM; Verdonschot EH
    Indian J Dermatol Venereol Leprol; 2014; 80(6):521-5. PubMed ID: 25382509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia.
    Tang L; Bernardo O; Bolduc C; Lui H; Madani S; Shapiro J
    J Am Acad Dermatol; 2003 Aug; 49(2):229-33. PubMed ID: 12894070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
    Whiting DA; Olsen EA; Savin R; Halper L; Rodgers A; Wang L; Hustad C; Palmisano J;
    Eur J Dermatol; 2003; 13(2):150-60. PubMed ID: 12695131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Androgenetic alopecia: finasteride treated hair loss].
    Heinzl S
    Med Monatsschr Pharm; 1999 Apr; 22(4):124-7. PubMed ID: 10230220
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss.
    Won YY; Lew BL; Sim WY
    Dermatol Ther; 2018 Mar; 31(2):e12588. PubMed ID: 29464847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finasteride improves male pattern hair loss in a randomized study in identical twins.
    Stough DB; Rao NA; Kaufman KD; Mitchell C
    Eur J Dermatol; 2002; 12(1):32-7. PubMed ID: 11809593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Androgenetic alopecia. Current aspects of a common phenotype].
    Hanneken S; Ritzmann S; Nöthen MM; Kruse R
    Hautarzt; 2003 Aug; 54(8):703-12. PubMed ID: 12942184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.
    Keene S; Goren A
    Dermatol Ther; 2011; 24(2):296-300. PubMed ID: 21410621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. My hair is thinning on the top of my head. What treatments are available for hair loss in women?
    Olsen EA
    Health News; 2002 Mar; 8(3):12. PubMed ID: 11910844
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of androgenetic alopecia.
    Bolduc C; Shapiro J
    Am J Clin Dermatol; 2000; 1(3):151-8. PubMed ID: 11702296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
    D'Amico AV; Roehrborn CG
    Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric androgenetic alopecia: an updated review.
    Gomes TF; Soares RO
    J Dtsch Dermatol Ges; 2023 Jan; 21(1):19-25. PubMed ID: 36688435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.